Literature DB >> 34396487

Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma.

Francesco Pasqualetti1, Nicola Montemurro2, Isacco Desideri3, Mauro Loi3, Noemi Giannini4, Giovanni Gadducci4, Giulia Malfatti4, Martina Cantarella4, Alessandra Gonnelli4, Sabrina Montrone4, Luca Visani3, Cristian Scatena5, Antonio Giuseppe Naccarato5, Paolo Perrini3, Carlo Gambacciani6, Orazio Santonocito6, Riccardo Morganti7, Fabiola Paiar4.   

Abstract

The impact of different patterns of glioblastoma (GBM) recurrence has not yet been fully established in patients suitable for a second surgery. Through the present observational study carried out at Pisa University Hospital, we aimed to investigate how different patterns of GBM failure influence second surgery outcomes. Overall survival (OS) and post-recurrence survival (PRS) were assessed according to clinical characteristics, including pattern of recurrence, in a prospective cohort of recurrent GBM patients. Survival curves were calculated using the Kaplan-Meier method and the log-rank test was applied to evaluate the differences between curves. Patients with local recurrence had better OS than patients with non-local one, 24.1 versus 18.2 months, respectively [P = 0.015, HR = 1.856 (1.130-3.050)]. The second surgery conferred an advantage in OS respect to non-operated patients, however, this advantage was more evident in patients with local recurrence [P = 0.002 with HR 0.212 (95% CI 0.081-0.552) and P = 0.029 with HR = 0.522 (95% CI 0.291-0.936), respectively]. The recurrence pattern can influence the outcome of patients with recurrent GBM suitable for a second surgery.
© 2021. Belgian Neurological Society.

Entities:  

Keywords:  Glioblastoma; Pattern of failure; Recurrent glioblastoma; Second surgery

Mesh:

Year:  2021        PMID: 34396487     DOI: 10.1007/s13760-021-01765-4

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  24 in total

1.  Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).

Authors:  Pierina Navarria; Giuseppe Minniti; Elena Clerici; Stefano Tomatis; Valentina Pinzi; Patrizia Ciammella; Marco Galaverni; Dante Amelio; Daniele Scartoni; Silvia Scoccianti; Marco Krengli; Laura Masini; Lorena Draghini; Ernesto Maranzano; Valentina Borzillo; Paolo Muto; Fabio Ferrarese; Laura Fariselli; Lorenzo Livi; Francesco Pasqualetti; Alba Fiorentino; Filippo Alongi; Michela Buglione di Monale; Stefano Magrini; Marta Scorsetti
Journal:  J Neurooncol       Date:  2018-12-04       Impact factor: 4.130

Review 2.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

Review 3.  Treatment options for recurrent high-grade gliomas.

Authors:  Harjus S Birk; Seunggu J Han; Nicholas A Butowski
Journal:  CNS Oncol       Date:  2016-12-21

4.  NRG brain tumor specialists consensus guidelines for glioblastoma contouring.

Authors:  Tim J Kruser; Walter R Bosch; Shahed N Badiyan; Joseph A Bovi; Amol J Ghia; Michelle M Kim; Abhishek A Solanki; Sean Sachdev; Christina Tsien; Tony J C Wang; Minesh P Mehta; Kevin P McMullen
Journal:  J Neurooncol       Date:  2019-03-19       Impact factor: 4.130

5.  Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration.

Authors:  Francesco Pasqualetti; Alessandra Gonnelli; Alessandro Molinari; Martina Cantarella; Sabrina Montrone; Agostino Cristaudo; Davide Baldaccini; Roberto Mattioni; Durim Delishaj; Valentina Mazzotti; Riccardo Morganti; Paola Cocuzza; Maria Grazia Fabrini; Giuseppe Lombardi; Roberta Rudà; Riccardo Soffietti; Fabiola Paiar
Journal:  Anticancer Res       Date:  2018-10       Impact factor: 2.480

6.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

7.  A single-institutional brachytherapy experience in the management of esophageal cancer.

Authors:  Maria Grazia Fabrini; Franco Perrone; Mario De Liguoro; Marianna Coppola; Stefano Santi; Biagio Solito; Monica Lencioni; Mauro Rossi; Luca Cionini
Journal:  Brachytherapy       Date:  2009-10-28       Impact factor: 2.362

8.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

Review 9.  EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.

Authors:  Michael Weller; Martin van den Bent; Matthias Preusser; Emilie Le Rhun; Jörg C Tonn; Giuseppe Minniti; Martin Bendszus; Carmen Balana; Olivier Chinot; Linda Dirven; Pim French; Monika E Hegi; Asgeir S Jakola; Michael Platten; Patrick Roth; Roberta Rudà; Susan Short; Marion Smits; Martin J B Taphoorn; Andreas von Deimling; Manfred Westphal; Riccardo Soffietti; Guido Reifenberger; Wolfgang Wick
Journal:  Nat Rev Clin Oncol       Date:  2020-12-08       Impact factor: 66.675

10.  Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume.

Authors:  Stefanie Bette; Melanie Barz; Thomas Huber; Christoph Straube; Friederike Schmidt-Graf; Stephanie E Combs; Claire Delbridge; Julia Gerhardt; Claus Zimmer; Bernhard Meyer; Jan S Kirschke; Tobias Boeckh-Behrens; Benedikt Wiestler; Jens Gempt
Journal:  Sci Rep       Date:  2018-03-14       Impact factor: 4.379

View more
  5 in total

1.  Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma.

Authors:  Francesco Pasqualetti; Giulia Malfatti; Martina Cantarella; Alessandra Gonnelli; Sabrina Montrone; Nicola Montemurro; Giovanni Gadducci; Noemi Giannini; Ilaria Pesaresi; Paolo Perrini; Riccardo Morganti; Mirco Cosottini; Fabiola Paiar
Journal:  Radiol Med       Date:  2022-05-24       Impact factor: 6.313

2.  Brain Tumor and Augmented Reality: New Technologies for the Future.

Authors:  Nicola Montemurro; Sara Condino; Marina Carbone; Nadia Cattari; Renzo D'Amato; Fabrizio Cutolo; Vincenzo Ferrari
Journal:  Int J Environ Res Public Health       Date:  2022-05-23       Impact factor: 4.614

3.  Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression.

Authors:  Chenkai Ma; Hong P T Nguyen; Jordan J Jones; Stanley S Stylli; Clarissa A Whitehead; Lucy Paradiso; Rodney B Luwor; Zammam Areeb; Eric Hanssen; Ellie Cho; Ulrich Putz; Andrew H Kaye; Andrew P Morokoff
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

4.  A Novel Necroptosis-Related Prognostic Signature of Glioblastoma Based on Transcriptomics Analysis and Single Cell Sequencing Analysis.

Authors:  Yiwen Wu; Yi Huang; Chenhui Zhou; Haifeng Wang; Zhepei Wang; Jiawei Wu; Sheng Nie; Xinpeng Deng; Jie Sun; Xiang Gao
Journal:  Brain Sci       Date:  2022-07-26

5.  Polyunsaturated Fatty Acid-Enriched Lipid Fingerprint of Glioblastoma Proliferative Regions Is Differentially Regulated According to Glioblastoma Molecular Subtype.

Authors:  Albert Maimó-Barceló; Lucía Martín-Saiz; José A Fernández; Karim Pérez-Romero; Santiago Garfias-Arjona; Mónica Lara-Almúnia; Javier Piérola-Lopetegui; Joan Bestard-Escalas; Gwendolyn Barceló-Coblijn
Journal:  Int J Mol Sci       Date:  2022-03-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.